Green Card Approved!
Another powerful success story!
We are thrilled to announce that our exceptional client has officially received her Green Card through the EB2-NIW category, approved with Premium Processing and no interview. Her work manufacturing innovative active pharmaceutical ingredients for breast cancer treatment affirms its national importance to U.S. public health and a resilient domestic drug supply chain.
| Processing Type | Premium Processing |
| Priority Date | June 14, 2024 |
| I-140 Approved | July 15, 2024 |
| I-485 Filed | October 2, 2025 |
| Biometrics | November 14, 2025 |
| Green Card Approved | July 18, 2026 |
| Field of Expertise | Pharmaceutical manufacturing, active pharmaceutical ingredient (API) development, and cancer therapeutics |
| Degrees | Doctor of Pharmacy (PharmD) M.Sc. Pharmaceutical Engineering |
Professional Highlights
- Pharmaceutical scientist specializing in manufacturing highly potent active pharmaceutical ingredients in line with FDA guidelines
- Licensed to practice pharmacy in three countries: the United States, the European Union, and Nigeria
- Experience across industrial and clinical pharmacy, quality control, and batch-process optimization
- Research spanning protein synthesis and antimicrobial studies, with published work in peer-reviewed outlets
Key Achievements
- 5 recommendation letters
- 24 certifications and trainings
- Licensed pharmacist in 3 countries
- 4 publications and research projects
- Membership in 4 professional societies
- 4 scholarships, 3 awards, and 2 speaker invitations
Why This Petition Succeeded
Substantial Merit & National Importance. Her endeavor was tied directly to U.S. public-health priorities and the need for a resilient domestic supply of active pharmaceutical ingredients, particularly for breast cancer treatment.
Well Positioned to Advance the Endeavor. Advanced degrees, licensure in three countries, peer-reviewed publications, awards, and active professional standing established her as uniquely qualified to deliver on the proposed work.
Labor Certification Waiver Justified. Her specialized manufacturing expertise serves patients nationwide and strengthens national supply-chain resilience, demonstrating impact well beyond any single employer.
Proposed Endeavor
Developing and manufacturing innovative active pharmaceutical ingredients to improve the safety and effectiveness of breast cancer treatments, serving patients across the United States and strengthening a fragile pharmaceutical supply chain.
